Table 3.
Inhibition of contractility in ex vivo HMD assay of inhibitors SSCI-1, 3–6.
Compound | Ex vivo HMD IC50 (μM) |
---|---|
SSCI-3 | 2.7 |
SSCI-4 | 8.9 |
SSCI-5 | 11 |
SSCI-1 | >30 |
SSCI-6 | 130% at 10 |
Inhibition of contractility in ex vivo HMD assay of inhibitors SSCI-1, 3–6.
Compound | Ex vivo HMD IC50 (μM) |
---|---|
SSCI-3 | 2.7 |
SSCI-4 | 8.9 |
SSCI-5 | 11 |
SSCI-1 | >30 |
SSCI-6 | 130% at 10 |